Sean McCutcheon
Stock Analyst at Raymond James
(n/a)
# 4,460
Out of 4,829 analysts
5
Total ratings
n/a
Success rate
-46.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Holdings | Initiates: Outperform | $23 | $2.88 | +698.61% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $8.88 | +350.70% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $32.65 | +114.40% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $32.83 | +161.96% | 1 | Mar 13, 2024 |
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $2.88
Upside: +698.61%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $8.88
Upside: +350.70%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $32.65
Upside: +114.40%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $32.83
Upside: +161.96%